Literature DB >> 1370486

Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization.

S Kuroda1, S Otaka, T Miyazaki, M Nakao, Y Fujisawa.   

Abstract

The hepatitis B virus envelope gene encodes three transmembrane proteins in frame; S, the product of S gene; M, the product of M (pre-S2 + S) gene; and L, the product of L (pre-S1 + pre-S2 + S) gene. Unlike the S and M proteins, attempts to efficiently synthesize L proteins and assemble them into L protein particles in various eukaryotic cells have been unsuccessful, probably because of the presence of the pre-S1 peptide with an unknown function which appears to be inhibitory to the host secretory apparatus. To investigate the role of the pre-S1 peptide, we constructed an L gene fused with a synthetic gene for chicken-lysozyme signal peptide (C-SIG) at the 5'-terminal and placed the resultant gene under the control of the yeast glyceraldehyde-3-phosphate dehydrogenase gene promoter. After the fused-C-SIG peptide was correctly processed by the yeast secretory apparatus, a yeast transformant synthesized a protein with a molecular mass of approximately 52 kDa at a level of 42% of the total soluble protein. Electron micrographic observation showed that the gene products assembled into 23-nm spherical and filamentous particles. The pre-S peptide of the gene product was deposited into the endoplasmic reticulum (ER) lumen and well-glycosylated. It seemed that the gene products were accumulated as particles in certain specific membrane structures of the yeast secretory apparatus. Moreover, both the amount of mRNAs specific for the L gene and the in vivo stability of the synthesized L proteins did not change significantly by the addition of the C-SIG gene. These findings indicated that, if the pre-S1 peptide penetrates the ER membrane efficiently, the L proteins can be synthesized cotranslationally, translocate across the ER membrane with its S region, and then assemble by themselves into the particle form. Therefore, the pre-S1 peptide may involve weak or reduced signal peptide activity for recognition by the secretory apparatus and/or for the transport of the pre-S peptide into the ER lumen.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Deciphering the mystery of hepatitis B virus receptors: A historical perspective.

Authors:  Zaira Rehman; Ammad Fahim; Hajra Sadia
Journal:  Virusdisease       Date:  2015-07-03

2.  Stabilization of methionine-rich protein in Saccharomyces cerevisiae: targeting of BZN protein into the peroxisome.

Authors:  J M Nicaud; A Raynal; A Beyou; M Merkamm; H Ito; N Labat
Journal:  Curr Genet       Date:  1994 Nov-Dec       Impact factor: 3.886

3.  Saccharomyces cerevisiae can release hepatitis B virus surface antigen (HBsAg) particles into the medium by its secretory apparatus.

Authors:  S Kuroda; T Miyazaki; S Otaka; Y Fujisawa
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

4.  Polymerized Albumin Receptor of Hepatitis B Virus for Evading the Reticuloendothelial System.

Authors:  Kurumi Takagi; Masaharu Somiya; Joohee Jung; Masumi Iijima; Shun'ichi Kuroda
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-25

5.  Nano-visualization of oriented-immobilized IgGs on immunosensors by high-speed atomic force microscopy.

Authors:  Masumi Iijima; Masaharu Somiya; Nobuo Yoshimoto; Tomoaki Niimi; Shun'ichi Kuroda
Journal:  Sci Rep       Date:  2012-11-09       Impact factor: 4.379

6.  Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes.

Authors:  Yuya Nishimura; Hiroaki Mieda; Jun Ishii; Chiaki Ogino; Toshinobu Fujiwara; Akihiko Kondo
Journal:  J Nanobiotechnology       Date:  2013-06-24       Impact factor: 10.435

7.  Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.

Authors:  Qiushi Liu; Joohee Jung; Masaharu Somiya; Masumi Iijima; Nobuo Yoshimoto; Tomoaki Niimi; Andrés D Maturana; Seol Hwa Shin; Seong-Yun Jeong; Eun Kyung Choi; Shun'ichi Kuroda
Journal:  Int J Nanomedicine       Date:  2015-06-25

8.  Engineered hepatitis B virus surface antigen L protein particles for in vivo active targeting of splenic dendritic cells.

Authors:  Hidenori Matsuo; Nobuo Yoshimoto; Masumi Iijima; Tomoaki Niimi; Joohee Jung; Seong-Yun Jeong; Eun Kyung Choi; Tomomitsu Sewaki; Takeshi Arakawa; Shun'ichi Kuroda
Journal:  Int J Nanomedicine       Date:  2012-07-03

9.  Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment.

Authors:  A P Huovila; A M Eder; S D Fuller
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

10.  A display of pH-sensitive fusogenic GALA peptide facilitates endosomal escape from a Bio-nanocapsule via an endocytic uptake pathway.

Authors:  Yuya Nishimura; Koichi Takeda; Ryosuke Ezawa; Jun Ishii; Chiaki Ogino; Akihiko Kondo
Journal:  J Nanobiotechnology       Date:  2014-04-01       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.